Additional information
| Active substance | Temozolomide | 
|---|---|
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | CBC (Complete Blood Count) monitoring | 
| Also known as | TMZ, Methazolastone | 
| WAREHOUSE | International Warehouse 2 | 
| Blood pressure | No direct effect | 
| Trade name | Temodar, Temodal, Temcad | 
| Storage conditions | Store at controlled room temperature, 20-25В°C (68-77В°F) | 
| Chemical name | 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide | 
| Formula | C6H6N6O2 | 
| Substance class | Alkylating agent | 
| Main action | Antineoplastic | 
| Half-life | 1.8 hours | 
| Dosage (medical) | Typically 150-200 mg/mВІ per day for 5 days every 28 days cycle | 
| Dosage (sports) | Not applicable | 
| Effects | Antitumor effect, crosses the blood-brain barrier | 
| Side effects | Nausea, vomiting, constipation, loss of appetite, alopecia, headache, fatigue, neutropenia, thrombocytopenia | 
| Use in sports | None | 
| Manufacturer | MSD | 
 Prograf 5mg Astellas Pharma
							Prograf 5mg Astellas Pharma						 Zyban Glaxosmithkline
							Zyban Glaxosmithkline						 Fostimon (Merional) 150 IU HMG IBSA
							Fostimon (Merional) 150 IU HMG IBSA						 Prograf 1mg Astellas Pharma
							Prograf 1mg Astellas Pharma						 LACIPIL 4 mg Glaxosmithkline
							LACIPIL 4 mg Glaxosmithkline						

 
			 
			 
			 
			
Reviews
There are no reviews yet.